ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

Study: Molecular Breast Imaging Can Be As Effective as MRI

July 27, 2012

Includes May issue of Business & Regulatory Report.

May 31, 2002

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Velcade Improves Survival In Relapsed Multiple Myeloma

July 29, 2005

Army of Women, caBIG To Collaborate.

August 7, 2009

DCT Board Approves Concept To Recomplete Data Management Contract

June 29, 1984